DOCSLIB.ORG

The Pathology of Tangier Disease a Light and Electron Amicroscopic Study

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
The Pathology of Tangier Disease a Light and Electron Amicroscopic Study The Pathology of Tangier Disease A Light and Electron AMicroscopic Study Victor J. Ferrans, MD, PhD and Donald S. Fredrickson, MD Tangier disease (deficiency of high density plasma lipoprotems) is characterized clinically by: low levels of plasma cholesterol; enlarged, orange-yellow to yellow- gray tonsils and, frequently, penpheral neuropathy. Histologic and ultrastructural studies were made of various tissues from 5 patients with Tangier disease, and comparisons were made of these findings wih those in the 12 other patients thus far known to have this disease. Deposits of cholesteryl esters were found in: reticu- loendothelial cells (foam cells) in tonsils, bone marrow, skin and jejimal sub- mucosa; Schwann cells in peripheral nerves and myenteric plexus; and in non- vascular smooth muscle cells. These deposits appeared elecron lucent and in- tensely birefringent, varied from spherical to crystalline in shape, often were extensively confluent throughout large areas of cytoplasm, and were not limited by membranes. Certain foam cells in bone marrow also contained membrane- limited clusters of lipid particles resembling chylomicrons. The foam cells in Tangier disease differ morphologically from those in numerous lysosomal enzyme deficiency states, particularly Wolman's disease and cholesteryl ester storage disease, and in proliferative diseases of the reticuloendothelial system in which cholesteryl esters also accumulate in abnormal histiocytes. Morphologic and bio- chemical data suggest several hypothses to explain the accumulation of cholesteryl esters in tissues of patients with Tangier disease. Among these hypotheses, the most likely are considered to be the presence in plasma of abnormal lipoprotein particles that are subject to phagocytic removal by reticuloendothelial cells, and the failure of a process that normally removes locally synthesized cholesterol from cells to plasma. (Am J Pathol 78:101-158, 1975) TANGIER DISEASE is a rare disorder of plasma lipid transport thought to be due to a mutant autosomal gene.' The homozygous abnormal patient has the following features: a) low plasma cholesterol and normal or elevated triglyceride concentrations; b) absence of the usual high density lipoproteins (HDL) and abnormal composition of other lipoproteins in plasma; c) enlargement and distinctive colora- tion of the tonsils; d) widespread tissue storage of cholesteryl esters, especially prominent in reticuloendothelial cells in lymph nodes, thymus, tonsils, bone marrow and rectal mucosa; and often, e) neuropathy. The combination of low plasma cholesterol and enlarged, yellow- From the Section of Pathology and the Molecular Disease Branch, National Heart and Lung Institute, National Institutes of Health, Bethesda, Md. Accepted for publication September 10, 1974. Address reprint requests to Dr. Victor J. Ferrans, Section of Pathology, National Heart and Lung Institute, National Institutes of Health, Bethesda, MID 20014. 101 102 FERRANS AND FREDRICKSON American Journal of Pathology orange or yellow-gray tonsils or tonsillar remnants is considered pathognomonic of the disease.' Tangier disease was discovered in 1960 and given its name from Tangier Island, which lies off the coast of Virginia in the Chesapeake Bay and is the home of the original patients.2'3 As of this writing, 17 patients 2-14 have been discovered, representing 13 kindreds, none of which are known to be related. They include 10 Americans,2458 2 Germans,10 14 2 Australians,7'11'13 and 1 each from Switzerland,9 En- gland '7 and New Zealand.12 Fourteen have been described in previous reports,2-13 and 1 of these represented a presumptive diagnosis made at autopsy.13 Two patients are reported here for the first time (patients 15 and 16 in Tables 1 and 2). The seventeenth has been described to us in a personal communication,14 and is also included here. Some of the histopathologic features of Tangier disease have been described in reports of individual patients, but these have not been collated and reviewed. The ultrastructure of the foam cells has not been described in detail. This report provides light and electron micro- scopic observations in various tissues from 5 homozygotes with Tangier disease, as well as bone marrow studies in 1 obligate heterozygote, and reviews all other reported pathologic lesions in the context of current knowledge concerning the possible pathogenesis of Tangier disease. Case Reports Clinical and morphologic data on the 5 patients described in detail in this com- munication are summarized in Tables 1 and 2. All patients known to have Tangier disease are included in these tables, in which they are numbered according to chronologic order of diagnosis. This numbering system is also followed in the reports of individual patients and throughout the remainder of this communication. Patient 2 ELa (CC No. 03-28-36), a white girl borm in 1954, was first seen at the Clinical Center of the National Institutes of Health in 1960. This patient and her brother TLa (patient 1 in Tables 1 and 2) were the first patients diagnosed as having Tangier disease. As reported in detail elsewhere;2'3 the detection of foam cells in the operatively removed tonsils of TLa led to a survey of his family on Tangier Island. ELa was asymptomatic and in good health except for enlarged, orange- yellow tonsils similar to those of her brother. The only abnormal findings disclosed by extensive laboratory studies were in plasma lipids and lipoproteins. Concentra- tions of plasma lipids, given in mg/100 ml of plasma and followed within paren- theses by mean normal values for children,2 were as follows: total cholesterol, 85 (170), of which 23 (46) was in the form of free cholesterol; triglycerides, 237 (40), and total phospholipids, 82 (230). After paper electrophoresis of plasma, no stain- able lipid was visible in the a-lipoprotein region. The high density lipoprotein fraction (density 1.063 to 1.21) contained only 2 mg/100 ml of cholesterol (mean Vol. 78, No. 1 TANGIER DISEASE 103 January 1975 normal for females, age 1 to 19 years, 56). Her tosils were removed, and they contained many large, foamy histiocytes similar to those in her brother's tonsils. Tonslar lipids, in mg/g dry weight of tissue, followed within parentheses by normal values 15 were: total lipids, 162 (69); cholesteryl esters, 89 (1); free cholesterol, 20 (1), and total phspholipids, 63 (49). All of the sterol present in the tonsils was cholesterol and the major (61%) acyl component of the cholesteryl esters was oleic acid.15 The patient has been followed regularly at the Clinical Center. In 1969 she developed left peroneal nerve palsy with foot drop. ITis disappeared, recurred for several months, and finaly subsided entirely. In 1972, she also develped transient right foot drop. Her plasma lipoprotein abnormalities have perssted. In July, 1971, her plasma cholesterol was 62 mg/100 ml, and the triglycerides were 186 mg/100 ml; cholesterol concentrations in lipoprotein fractions were (in mg/100 ml of plasma, followed by normal values, ie, 90% fiducial limits for females ages 1 to 19 years,16 given within parentheses): very low density lipoproteins (VLDL) 17 (5- 25); low density hpoproteins (LDL) 44 (50-170); and high density lipoproteins (HDL), 1 (40-5). Examination of bone marrow (1961) by phase contrast and polarization microscopy revealed foam cells resembling those in her tonsils. A few foam cells with similar characteristics were found in bone marrow of her mother, but not of her father. Histologic study of punch biopsy (1965) of her slin failed to demon- strate the lipid-contaiing cells which have been found4 in the dermis of other patients with Tangier disease. Ught and electron microscopic observations on foam cells observed in the lamina propria of jejunal mucosa obtained by peroral biopsy in 1972 are described in this report. Patient 4 PeLo, (CC No. 05-32-90-3), a 19-year-old white girl, was diagnosed as having Tangier disease at age 7, when she had a tonsillectomy for greatly enlarged, orange tonsils. The tonsils were shown to contain deposits of cholesteryl esters and the patient was referred for evaluation to the Clinical Center of the National Institutes of Health. The patient was found to have a low plasma cholesterol and absence of a-lipoproteins. She also had congenital pulmonic valvular stenosis, a lesion which was operatively corrected when she was 10 years old. At that time, extensive deposits of cholesteryl esters were found in foam ceHls in the thymus and lymph nodes; small, focal deposits also were found in the wall of the pulmonary artery; atrial myocardium appeared free of lipid deposits.15 The patient did well postoperatively and has had no significant cardiac symptoms since then. She de- veloped insulin-dependent diabetes mellitus at age 14 and has had adequate control of this disease. She has no signs or symptoms of peripheral neuropathy and no hepatosplenomegaly. Her sister (patient 3 in Tables 1 and 2) also has Tangier disease. When last seen at the Clinical Center, in November of 1973, her plasma cholesterol was 101 mg/100 ml; triglycerides were 178 mg/100 mL Cholesterol concentrations in plasma lipoprotein fractions (in mg/100 ml of plasma) were: VLDL, 19; LDL, 73; and HDL, 9. A biopsy of chnically normal sin was taken for ulrastructural study. Patint 5 CNo, (CC No. 04-93-64-8), a 55-vear-old man, was first diagnosed as having Tangier disease in 1962,5 when he underwent evaluation of splenomegaly, mild anemia and intermittent diarrhea of several years' duration. His tonsils had been removed at age 14 because of marked enlargement. Physical examination disclosed fine comeal deposits such as those seen in other adults with Tangier disease,5 104 FERRANS AND FREDRICKSON American Journal of Pathology U) = ~~ 0CL 4--0a )-( 3: :p C) (n E uko ow. E E.~~E~L~~ ~ 0 a-4*- bt 0 a) 4.O '0 (U C )(-( E 0 E -c M CL4-1- 0 W) E3 :6 + +o o + + ++ + o ++ 0 + 0 o 76) a- 0 0 -a)0 I + + + I + + I ++ o a1) ' C 0 nU) 0tn (Ua) Eo a) U) + + + +0 + + .
Load more

Recommended publications
  • Some ABCA3 Mutations Elevate ER Stress and Initiate Apoptosis of Lung Epithelial Cells
    Some ABCA3 mutations elevate ER stress and initiate apoptosis of lung epithelial cells Nina Weichert Aus der Kinderklinik und Kinderpoliklinik im Dr. von Haunerschen Kinderspital der Ludwig-Maximilians-Universität München Direktor: Prof. Dr. med. Dr. sci. nat. Christoph Klein Some ABCA3 mutations elevate ER stress and initiate apoptosis of lung epithelial cells Dissertation zum Erwerb des Doktorgrades der Humanmedizin an der Medizinischen Fakultät der Ludwig-Maximilians-Universität zu München Vorgelegt von Nina Weichert aus Heidelberg 2011 Mit Genehmigung der Medizinischen Fakultät der Universität München 1. Berichterstatter: Prof. Dr. Matthias Griese 2. Berichterstatter: Prof. Dr. Dennis Nowak Mitberichterstatter: Priv. Doz. Dr. Angela Abicht Prof. Dr. Michael Schleicher Mitbetreuung durch den promovierten Mitarbeiter: Dr. Suncana Kern Dekan: Herr Prof. Dr. med. Dr. h. c. Maximilian Reiser, FACR, FRCR Tag der mündlichen Prüfung: 24.11.2011 Table of Contents 1.Abstract ................................................................................................................... 1 2.Zusammenfassung................................................................................................. 2 3.Intoduction .............................................................................................................. 3 3.1 Pediatric interstitial lung disease ............................................................................... 3 3.1.1 Epidemiology of pILD..............................................................................................
    [Show full text]
  • Studies on the Absorptive Defect for Triglyceride in Abetalipoproteinemia * P
    Jownal of Clinical Investigation Vol. 46, No. 1, 1967 Studies on the Absorptive Defect for Triglyceride in Abetalipoproteinemia * P. 0. WAYS,t C. M. PARMENTIER, H. J. KAYDEN,4 J. W. JONES,§ D. R. SAUNDERS,|| AND C. E. RUBIN 1J (From the Department of Medicine, University of Washington School of Medicine, Seattle, Wash., and the Department of Medicine, New York University School of Medicine, New York, N. Y.) Summary. The nature of the gastrointestinal absorptive defect for triglycer- ide in three subjects with abetalipoproteinemia has been investigated by studying peroral biopsies of the gastrointestinal mucosa. The following con- clusions were reached. 1) In confirmation of other studies, the abnormal vacuoles within the du- odenal absorptive cells of these individuals were lipophilic. 2) On chemical analysis there was significantly more mucosal lipid than found in normal fasting specimens, and almost the entire increase was due to triglyceride. 3) This excess mucosal lipid was reduced by a low fat diet, but even after 34 days on such a diet there was still an excess of lipophilic material near the villus tip and increased quantities of total lipid and triglyceride when com- pared with material from normal subjects similarly treated. 4) Although there are demonstrable qualitative changes in mucosal and plasma lipids after an acute fat load, they are not quantitatively as great as in normal individuals. Fat balance studies and the qualitative changes in plasma and tissue lipids that do occur after more extended periods on different types of dietary fat do indicate that a considerable percentage of the dietary fat is assimilated.
    [Show full text]
  • Genes in Eyecare Geneseyedoc 3 W.M
    Genes in Eyecare geneseyedoc 3 W.M. Lyle and T.D. Williams 15 Mar 04 This information has been gathered from several sources; however, the principal source is V. A. McKusick’s Mendelian Inheritance in Man on CD-ROM. Baltimore, Johns Hopkins University Press, 1998. Other sources include McKusick’s, Mendelian Inheritance in Man. Catalogs of Human Genes and Genetic Disorders. Baltimore. Johns Hopkins University Press 1998 (12th edition). http://www.ncbi.nlm.nih.gov/Omim See also S.P.Daiger, L.S. Sullivan, and B.J.F. Rossiter Ret Net http://www.sph.uth.tmc.edu/Retnet disease.htm/. Also E.I. Traboulsi’s, Genetic Diseases of the Eye, New York, Oxford University Press, 1998. And Genetics in Primary Eyecare and Clinical Medicine by M.R. Seashore and R.S.Wappner, Appleton and Lange 1996. M. Ridley’s book Genome published in 2000 by Perennial provides additional information. Ridley estimates that we have 60,000 to 80,000 genes. See also R.M. Henig’s book The Monk in the Garden: The Lost and Found Genius of Gregor Mendel, published by Houghton Mifflin in 2001 which tells about the Father of Genetics. The 3rd edition of F. H. Roy’s book Ocular Syndromes and Systemic Diseases published by Lippincott Williams & Wilkins in 2002 facilitates differential diagnosis. Additional information is provided in D. Pavan-Langston’s Manual of Ocular Diagnosis and Therapy (5th edition) published by Lippincott Williams & Wilkins in 2002. M.A. Foote wrote Basic Human Genetics for Medical Writers in the AMWA Journal 2002;17:7-17. A compilation such as this might suggest that one gene = one disease.
    [Show full text]
  • Bovine Milk Lipoprotein Lipase Transfers Tocopherol to Human Fibroblasts During Triglyceride Hydrolysis in Vitro Maret G
    Bovine Milk Lipoprotein Lipase Transfers Tocopherol to Human Fibroblasts during Triglyceride Hydrolysis In Vitro Maret G. Traber, Thomas Olivecrona, and Herbert J. Kayden Department ofMedicine, New York University School ofMedicine, New York 10016; University of Umea, Umea, Sweden Abstract vitamin E, have minimal or absent neurological abnormalities, but those who have not been supplemented have a progressive Lipoprotein lipase appears to function as the mechanism by which dietary vitamin E (tocopherol) is transferred from chy- degeneration of the peripheral nervous system resulting in ataxia and characteristic pathologic changes in the central lomicrons to tissues. In patients with lipoprotein lipase defi- nervous system (5). These neuropathologic changes have been more than 85% of both the and ciency, circulating triglyceride observed in patients with cholestatic liver disease in whom the tocopherol is contained in the chylomicron fraction. The studies in low to absent levels of bile salts in the intestine results in an presented here show that the vitro addition of bovine milk inability to absorb vitamin E (3). Oral supplementation with to in the of lipoprotein lipase (lipase) chylomicrons presence pharmacologic amounts of the vitamin (6), or or fibroblasts bovine albumin pagenteral human erythrocytes (and serum administration of the vitamin (when there is a complete resulted in the hydrolysis of triglyceride and the [BSAJ) the absence of intestinal bile) (7) results in the prevention of transfer of both acids and to the in the fatty tocopherol cells; further of the nervous system. The studies in absence of no in cellular was deterioration lipase, increase tocopherol these two groups ofpatients have demonstrated the importance The incubation was to include detectable.
    [Show full text]
  • WES Gene Package Multiple Congenital Anomalie.Xlsx
    Whole Exome Sequencing Gene package Multiple congenital anomalie, version 5, 1‐2‐2018 Technical information DNA was enriched using Agilent SureSelect Clinical Research Exome V2 capture and paired‐end sequenced on the Illumina platform (outsourced). The aim is to obtain 8.1 Giga base pairs per exome with a mapped fraction of 0.99. The average coverage of the exome is ~50x. Duplicate reads are excluded. Data are demultiplexed with bcl2fastq Conversion Software from Illumina. Reads are mapped to the genome using the BWA‐MEM algorithm (reference: http://bio‐bwa.sourceforge.net/). Variant detection is performed by the Genome Analysis Toolkit HaplotypeCaller (reference: http://www.broadinstitute.org/gatk/). The detected variants are filtered and annotated with Cartagenia software and classified with Alamut Visual. It is not excluded that pathogenic mutations are being missed using this technology. At this moment, there is not enough information about the sensitivity of this technique with respect to the detection of deletions and duplications of more than 5 nucleotides and of somatic mosaic mutations (all types of sequence changes). HGNC approved Phenotype description including OMIM phenotype ID(s) OMIM median depth % covered % covered % covered gene symbol gene ID >10x >20x >30x A4GALT [Blood group, P1Pk system, P(2) phenotype], 111400 607922 101 100 100 99 [Blood group, P1Pk system, p phenotype], 111400 NOR polyagglutination syndrome, 111400 AAAS Achalasia‐addisonianism‐alacrimia syndrome, 231550 605378 73 100 100 100 AAGAB Keratoderma, palmoplantar,
    [Show full text]
  • Commonly Used Lipidcentric ICD-10 (ICD-9) Codes
    Commonly Used Lipidcentric ICD-10 (ICD-9) Codes *This is not an all inclusive list of ICD-10 codes R.LaForge 11/2015 E78.0 (272.0) Pure hypercholesterolemia E78.3 (272.3) Hyperchylomicronemia (Group A) (Group D) Familial hypercholesterolemia Grütz syndrome Fredrickson Type IIa Chylomicronemia (fasting) (with hyperlipoproteinemia hyperprebetalipoproteinemia) Hyperbetalipoproteinemia Fredrickson type I or V Hyperlipidemia, Group A hyperlipoproteinemia Low-density-lipoid-type [LDL] Lipemia hyperlipoproteinemia Mixed hyperglyceridemia E78.4 (272.4) Other hyperlipidemia E78.1 (272.1) Pure hyperglyceridemia Type 1 Diabetes Mellitus (DM) with (Group B) hyperlipidemia Elevated fasting triglycerides Type 1 DM w diabetic hyperlipidemia Endogenous hyperglyceridemia Familial hyperalphalipoproteinemia Fredrickson Type IV Hyperalphalipoproteinemia, familial hyperlipoproteinemia Hyperlipidemia due to type 1 DM Hyperlipidemia, Group B Hyperprebetalipoproteinemia Hypertriglyceridemia, essential E78.5 (272.5) Hyperlipidemia, unspecified Very-low-density-lipoid-type [VLDL] Complex dyslipidemia hyperlipoproteinemia Elevated fasting lipid profile Elevated lipid profile fasting Hyperlipidemia E78.2 (272.2) Mixed hyperlipidemia (Group C) Hyperlipidemia (high blood fats) Broad- or floating-betalipoproteinemia Hyperlipidemia due to steroid Combined hyperlipidemia NOS Hyperlipidemia due to type 2 diabetes Elevated cholesterol with elevated mellitus triglycerides NEC Fredrickson Type IIb or III hyperlipoproteinemia with E78.6 (272.6)
    [Show full text]
  • Coexpression of ATP-Binding Cassette Proteins ABCG5 and ABCG8 Permits Their Transport to the Apical Surface
    Coexpression of ATP-binding cassette proteins ABCG5 and ABCG8 permits their transport to the apical surface Gregory A. Graf, … , Jonathan C. Cohen, Helen H. Hobbs J Clin Invest. 2002;110(5):659-669. https://doi.org/10.1172/JCI16000. Article Cardiology Mutations in either ATP-binding cassette (ABC) G5 or ABCG8 cause sitosterolemia, an autosomal recessive disorder of sterol trafficking. To determine the site of action of ABCG5 and ABCG8, we expressed recombinant, epitope-tagged mouse ABCG5 and ABCG8 in cultured cells. Both ABCG5 and ABCG8 underwent N-linked glycosylation. When either protein was expressed individually in cells, the N-linked sugars remained sensitive to Endoglycosidase H (Endo H). When ABCG5 and ABCG8 were coexpressed, the attached sugars were Endo H–resistant and neuraminidase-sensitive, indicating that the proteins were transported to the trans-Golgi complex. The mature, glycosylated forms of ABCG5 and ABCG8 coimmunoprecipitated, consistent with heterodimerization of these two proteins. The Endo H–sensitive forms of ABCG5 and ABCG8 were confined to the endoplasmic reticulum (ER), whereas the mature forms were present in non-ER fractions in cultured hepatocytes. Immunoelectron microscopy revealed ABCG5 and ABCG8 on the plasma membrane of these cells. In polarized WIF-B cells, recombinant ABCG5 localized to the apical (canalicular) membrane when coexpressed with ABCG8, but not when expressed alone. To our knowledge this is the first direct demonstration that trafficking of an ABC half-transporter to the cell surface requires the presence of its dimerization partner. Find the latest version: https://jci.me/16000/pdf Coexpression of ATP-binding cassette See the related Commentary beginning on page 605.
    [Show full text]
  • 'Sitosterolemia—10 Years Observation in Two Sisters'
    Zurich Open Repository and Archive University of Zurich Main Library Strickhofstrasse 39 CH-8057 Zurich www.zora.uzh.ch Year: 2019 Sitosterolemia—10 years observation in two sisters Veit, Lara ; Allegri Machado, Gabriella ; Bürer, Céline ; Speer, Oliver ; Häberle, Johannes Abstract: Familial hypercholesterolemia due to heterozygous low‐density lipoprotein‐receptor mutations is a common inborn errors of metabolism. Secondary hypercholesterolemia due to a defect in phytosterol metabolism is far less common and may escape diagnosis during the work‐up of patients with dyslipi- demias. Here we report on two sisters with the rare, autosomal recessive condition, sitosterolemia. This disease is caused by mutations in a defective adenosine triphosphate‐binding cassette sterol excretion transporter, leading to highly elevated plant sterol concentrations in tissues and to a wide range of symp- toms. After a delayed diagnosis, treatment with a diet low in plant lipids plus ezetimibe to block the absorption of sterols corrected most of the clinical and biochemical signs of the disease. We followed the two patients for over 10 years and report their initial presentation and long‐term response to treatment. DOI: https://doi.org/10.1002/jmd2.12038 Posted at the Zurich Open Repository and Archive, University of Zurich ZORA URL: https://doi.org/10.5167/uzh-182906 Journal Article Accepted Version Originally published at: Veit, Lara; Allegri Machado, Gabriella; Bürer, Céline; Speer, Oliver; Häberle, Johannes (2019). Sitosterolemia— 10 years observation in
    [Show full text]
  • Fat Accumulation in Enterocytes: a Key to the Diagnosis of Abetalipoproteinemia Or Homozygous Hypobetalipoproteinemia
    Cases and Techniques Library (CTL) E223 Fat accumulation in enterocytes: a key to the diagnosis of abetalipoproteinemia or homozygous hypobetalipoproteinemia Fig. 3 Microscopic image showing vacuo- lization, especially on the top of the villi. Vacuolization causes a paler aspect because of fat dissolving during the process of embed- ding the tissue in par- affin wax (“empty” vacuoles instead of fat accumulation). Fig. 4 Negative peri- Fig. 1 A 20-year-old woman was referred by odic acid-Schiff staining her ophthalmologist to investigate the reason shows no microorgan- for her hypovitaminosis A and secondary night isms nor accumulation blindness. A macroscopic image taken during of glycogen, supporting gastroscopy shows a pale duodenal mucosa. the assumption that the vacuolization is due to lipid accumulation. level of detection). Her level of 25-hydroxy These findings suggested a diagnosis of Fig. 2 Videocapsule image illustrating the vitamin D appeared to be normal, but at either abetalipoproteinemia or homo- pale yet pronounced aspect of the villi. the time of her first admission, vitamin D zygous hypolipobetaproteinemia, disor- substitution had already been started. A ders that are caused by mutations in both This document was downloaded for personal use only. Unauthorized distribution is strictly prohibited. slightly raised alanine aminotransferase alleles of the microsomal triglycerides A 20-year-old woman was referred by her was also detected (33U/L). transfer protein (MTP) or in the APO-B ophthalmologist to investigate the reason Further work-up excluded cystic fibrosis, gene, respectively [1–2] This results in for her hypovitaminosis A and secondary exocrine pancreas insufficiency, and celiac the failure of APO B-100 synthesis in the night blindness.
    [Show full text]
  • Evaluation and Treatment of Hypertriglyceridemia: an Endocrine Society Clinical Practice Guideline
    SPECIAL FEATURE Clinical Practice Guideline Evaluation and Treatment of Hypertriglyceridemia: An Endocrine Society Clinical Practice Guideline Lars Berglund, John D. Brunzell, Anne C. Goldberg, Ira J. Goldberg, Frank Sacks, Mohammad Hassan Murad, and Anton F. H. Stalenhoef University of California, Davis (L.B.), Sacramento, California 95817; University of Washington (J.D.B.), Seattle, Washington 98195; Washington University School of Medicine (A.C.G.), St. Louis, Missouri 63110; Columbia University (I.J.G.), New York, New York 10027; Harvard School of Public Health (F.S.), Boston, Massachusetts 02115; Mayo Clinic (M.H.M.), Rochester, Minnesota 55905; and Radboud University Nijmegen Medical Centre (A.F.H.S.), 6525 GA Nijmegen, The Netherlands Objective: The aim was to develop clinical practice guidelines on hypertriglyceridemia. Participants: The Task Force included a chair selected by The Endocrine Society Clinical Guidelines Subcommittee (CGS), five additional experts in the field, and a methodologist. The authors received no corporate funding or remuneration. Consensus Process: Consensus was guided by systematic reviews of evidence, e-mail discussion, conference calls, and one in-person meeting. The guidelines were reviewed and approved sequen- tially by The Endocrine Society’s CGS and Clinical Affairs Core Committee, members responding to a web posting, and The Endocrine Society Council. At each stage, the Task Force incorporated changes in response to written comments. Conclusions: The Task Force recommends that the diagnosis of hypertriglyceridemia be based on fasting levels, that mild and moderate hypertriglyceridemia (triglycerides of 150–999 mg/dl) be diagnosed to aid in the evaluation of cardiovascular risk, and that severe and very severe hyper- triglyceridemia (triglycerides of Ͼ 1000 mg/dl) be considered a risk for pancreatitis.
    [Show full text]
  • Angioid Streaks Associated with Abetalipoproteinemia
    Ophthalmic Genetics ISSN: 1381-6810 (Print) 1744-5094 (Online) Journal homepage: http://www.tandfonline.com/loi/iopg20 Angioid streaks associated with abetalipoproteinemia Michael B. Gorin, T. Otis Paul & Daniel J. Rader To cite this article: Michael B. Gorin, T. Otis Paul & Daniel J. Rader (1994) Angioid streaks associated with abetalipoproteinemia, Ophthalmic Genetics, 15:3-4, 151-159, DOI: 10.3109/13816819409057843 To link to this article: http://dx.doi.org/10.3109/13816819409057843 Published online: 08 Jul 2009. Submit your article to this journal Article views: 7 View related articles Full Terms & Conditions of access and use can be found at http://www.tandfonline.com/action/journalInformation?journalCode=iopg20 Download by: [UCLA Library] Date: 02 May 2017, At: 14:12 0Ophthalmic Genetics 0167-6784/94/ Angioid streaks associated with US$ 3.50 abetalipoproteinemia Ophthalmic Genetics - 1994, Vol. 15, No. 3/4pp. 151-159 Michael B. Gorin’ 0Eolus Press T. Otis Paul2 Buren (The Netherlands) 1994 Daniel J. Rader3* Accepted 10 September 1994 Departments of Ophthalmology and Human Genetics, University of Pittsburgh School of Medicine and Graduate School of Public Health, Pittsburgh, PA 1521 3 Smith-Kettlewell Eye Research Institute, San Francisco, CA 941 15 Molecular Disease Branch; National Heart, Lung, and Blood Institute; National Institutes of Health, Bethesda, MD 20892 USA Abstract Angioid streaks were observed in two patients with abetalipo- Acknowledgements: The authors wish proteinemia. The progression of the angioid streaks was minimal over the to thank Dr. R. E. Anderson for years that these patients received vitamin A and E supplementation, though performing serum lipid analyses of in one patient the development of subretinal neovascular membranes within these patients and for his helpful the angioid streaks was the cause of rapid central visual loss.
    [Show full text]
  • Clinical Reasoning: Complex Ataxia Unpicking the Threads
    RESIDENT & FELLOW SECTION Clinical Reasoning: Complex ataxia Unpicking the threads Tarig Abkur, MRCP(UK), Kayal Vijayakumar, MRCPCH, Amanda J. Churchill, PhD, FRCOphth, and Correspondence James Stevens, MA, PhD, FRCP, DTM&H Tarig Abkur [email protected] Neurology® 2020;95:136-141. doi:10.1212/WNL.0000000000009886 Section 1 A 20-year-old right-handed woman was seen in neurology clinic for evaluation of progressive unsteadiness. Her symptoms began at age 10, with clumsiness and frequent falls. Her toes gradually became clawed, requiring bilateral cavovarus foot corrective surgery. She reported no sensory symptoms or visual or sphincter disturbance. The patient’s older brother had similar symptoms, as did both of her twin sisters, at age 12. There was no similar history in her parents’ families. Her parents and her mother’s parents are first cousins (figure 1). On examination, the patient had a full range of eye movements, but pursuit movements were broken. Saccadic eye movements were normal and there was no nystagmus evident. Figure 1 Family pedigree chart Circles indicate female family members, and squares male family members; slashes indicate that the family member is deceased. Family members with neurological involvement are indicated by solid symbols, and those without by open symbols. From the Department of Neurology (T.A., J.S.), Southmead Hospital; Department of Paediatric Neurology (K.V.), University Hospital Bristol NHS Foundation Trust; School of Medicine (K.V., A.J.C., J.S.), University of Bristol; and Department of Ophthalmology (A.J.C.), Bristol Eye Hospital, UK. Go to Neurology.org/N for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.
    [Show full text]